Clinical trial
Assessment of Compliance With Antihypertensive Telmisartan Therapy
NCT00470886 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00470886 |
|---|---|
| Title | Assessment of Compliance With Antihypertensive Telmisartan Therapy |
| Official title | A Non-Interventional, Post-Marketing Surveillance, Phase IV Study to Assess Compliance With Antihypertensive Telmisartan Therapy |
| Acronym | COAST |
| Lead sponsor | Bayer, Industry |
| Collaborators | Bang & Olufsen Medicom Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Telmisartan (Kinzal/Pritor, BAY68-9291) |
| Enrollment | 3,400 |
| Start date | Apr 1, 2007 |
| Primary completion | Jan 1, 2010 |
| Completion | Jan 1, 2010 |
| First posted | May 8, 2007 |
| Last update posted | Nov 16, 2012 |
| Countries | Poland, Slovakia |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: